Last reviewed · How we verify

NCT05788952: UNRAVEL

The Role of Intestinal and Vaginal Microbiota, Estrogenic Activity, Metabolic Profile & Nutritional Status in Endometriosis

Status unknown Last updated 29 March 2023
What this trial tests

trial in Endometriosis in 60 participants. Status unknown.

Timeline
1 June 2023
Primary endpoint
1 June 2024
1 December 2024

Quick facts

Lead sponsorUniversidade Nova de Lisboa
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date1 June 2023
Primary completion1 June 2024
Estimated completion1 December 2024
Sites1 location across Portugal

Conditions studied

Sponsor

Universidade Nova de Lisboa — full company profile →

Who can join

18 and older, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endometriosis (EMs) is one of the most prevalent benign gynaecological diseases, and it is an inflammatory oestrogen-dependent condition. Several authors have proposed that anatomical, genetic, endocrine, immunological, environmental, hormonal, and inflammatory factors may influence tissue implantation outside the uterus. An approach to EMs aetiology that involves defining a profile to the vaginal and gut microbiota, estrogenic activity, and exposure to xenoestrogens and also metabolic and nutritional status of women with EMs may help identify some important patterns to better characterize this disease and also to define more personalized nutritional strategies, also predicting patients' predisposition to therapy success. This is an observational study on premenopausal woman, diagnosed with EMs, who will be recruited on the outpatient gynaecology appointment, to evaluate the vaginal and intestinal microbiome, measure the total estrogenic activity, assess the metabolic biomarkers and the nutritional status.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Universidade Nova de Lisboa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05788952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing